DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Morgan Stanley Maintains Equal-Weight on Global Blood Therapeutics, Lowers Price Target to $71

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and lowers the price target from $80 to $71.

Benzinga · 03/03/2020 13:13

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and lowers the price target from $80 to $71.